Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT04000529 |
Title | Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | Yes |
Sponsors | Novartis Pharmaceuticals |
Indications |
gastrointestinal stromal tumor |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA | ESP | DEU | BEL |